Article
Joint Assessment Mechanism to Determine Pandemic Origins
NTI is working with international partners to create a new international mechanism to rapidly assess pandemic origins.
2022 Next Gen for Biosecurity Competition Challenge: Developing New Verification Strategies for the Biological Weapons Convention
Today, leaders preparing for the BWC’s Ninth Review Conference in August are exploring whether the global community can leverage increased attention and political will to strengthen the BWC by building mechanisms that increase transparency and trust with the goal of reducing the risk of global catastrophic biological events. A particular aim is determining whether there are effective and politically viable ways to enforce the treaty.
Past Event
Rewriting the Nuclear Story: U.S. Cultural Audit Research Findings
2:30PM EDT
Leader of World’s Largest Biotech Advocacy Organization, Michelle McMurry-Heath, Joins NTI’s Board of Directors
A global leader in science policy with a background in biosecurity, McMurry-Heath is a medical doctor and immunologist whose career spans government, the pharmaceutical industry, and biotechnology.
Article
Michelle McMurry-Heath
Multi-Track Diplomacy Explained
NTI’s 2021 Annual Report: 20 Years of Building a Safer World
The 2021 Annual Report illustrates how NTI makes an impact, details the organization’s financials, and thanks our generous supporters.
Russia’s Kinzhal Hypersonic Missile: A Game-Changing Weapon or a Distraction?
Jaime Yassif, Ph.D., Named Vice President, Global Biological Policy and Programs at NTI
Yassif will oversee NTI | bio’s work to reduce global catastrophic biological risks, strengthen biosecurity and pandemic preparedness, and build accountability for global health security progress.
Page